Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.13 USD
Change Today -0.05 / -4.24%
Volume 8.9K
RELV On Other Exchanges
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

reliv international inc (RELV) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/29/14 - $2.48
52 Week Low
04/10/15 - $1.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

reliv international inc (RELV) Related Businessweek News

No Related Businessweek News Found

reliv international inc (RELV) Details

Reliv International Inc. develops, manufactures, and markets proprietary nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. It also offers skin-care products, including balanced cleansing gel, body renewal lotion, smooth-and-lift serum, daily skin defense, eye renewal cream, nightly skin restore, and rich cleansing bar. It markets its products through a network of independent distributors in the U.S., Australia, Austria, Canada, Germany, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and Britain. The company was founded in 1984 and is headquartered in Chesterfield, Mo.

195 Employees
Last Reported Date: 03/24/15
Founded in 1984

reliv international inc (RELV) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $631.9K
President of Asia-Pacific Region
Total Annual Compensation: $202.0K
Senior Vice President, General Counsel, Secre...
Total Annual Compensation: $236.0K
Vice Chairman, Chief Scientific Officer, Memb...
Total Annual Compensation: $354.0K
Compensation as of Fiscal Year 2014.

reliv international inc (RELV) Key Developments

Reliv International Unveils New Lunarich X Encapsulation Line

Reliv International, Inc. announced that the company has installed a new encapsulation line at Reliv headquarters to manufacture LunaRich X(TM), a concentrated lunasin supplement. Reliv made the announcement to its distributors this week via a one-minute video. LunaRich X is the most pure, concentrated form of bioactive lunasin ever produced. Since its launch in January 2013, LunaRich X was named Consumer Product of the Year by the American Business Awards, was shown to aid in promoting metabolic health in a University of Missouri study and has sold more than 12 million capsules worldwide.

Reliv International, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Reliv International, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $14.1 million compared with sales of $17.4 million for the fourth quarter of 2013. Net income was $998,000, or $0.08 per diluted share compared with net income of $503,000, or $0.04 per diluted share, for the fourth quarter of 2013. Income from operations was $513,000 compared with $888,000 in the same quarter of 2013. Income before income tax was $423,323 compared to $824,830 a year ago. For the full year, the company reported net sales of $57.3 million compared with net sales of $68.2 million in 2013. Net income was $725,000 compared with $777,000 in 2013. Earnings per diluted share were $0.06 for both 2014 and 2013. Net income was favorably impacted by the income tax benefit in the European subsidiary as previously noted. Income from operations was $96,000 compared to $1.5 million in 2013. Net cash of $392,000 was used in operating activities in 2014 compared to net cash of $2.5 million provided by operations in 2013. Loss before income tax was $23,431 compared to income before income tax of $4,431,590 a year ago.

Reliv International, Inc. Reports Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Reliv International, Inc. reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2014. Net sales for the quarter were $14.3 million, a 13.5% decrease from the third quarter last year. U.S. net sales totaled $10.9 million, a decrease of $2.2 million, or 16.8%, compared to third-quarter 2013 net sales. Net income for the third quarter of 2014 was $166,000 or $0.01 per diluted share, compared to $293,000 or $0.02 per diluted share in the 2013 third quarter. Income from operations for the third quarter of 2014 was $228,000 compared to $402,000 in the same quarter of 2013. Product sales were $13,206,275 against $15,241,597 a year ago. Income from operations was $227,652 against $402,014 a year ago. Income before income taxes was $172,962 against $445,704 a year ago. Reliv reported a net loss of $274,000, or $0.02 per diluted share in the first nine months of 2014, compared to net income $274,000 or $0.02 per diluted share in the same period of 2013. Product sales were $39,867,425 against $46,296,517 a year ago. Loss from operations was $417,090 against income of $614,352 a year ago. Loss from operations was $446,754 against income of $606,760 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RELV:US $1.13 USD -0.05

RELV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lifevantage Corp $0.68 USD -0.0002
Lifeway Foods Inc $20.03 USD -0.22
Mannatech Inc $19.85 USD -0.56
Natural Alternatives International Inc $5.55 USD +0.04
Natural Health Trends Corp $20.36 USD +1.35
View Industry Companies

Industry Analysis


Industry Average

Valuation RELV Industry Range
Price/Earnings 20.9x
Price/Sales 0.3x
Price/Book 0.9x
Price/Cash Flow 20.9x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RELIV INTERNATIONAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at